What is Broadley-James?
Headquartered in Irvine, California, Broadley-James Corporation operates as a critical manufacturer of high-precision instrumentation, including pH, Redox, and Dissolved Oxygen sensors. Beyond sensor technology, the company provides sophisticated bioreactors and automation systems tailored for complex bioprocess applications. By positioning itself at the intersection of industrial science and biotechnology, Broadley-James serves as a foundational partner for organizations requiring rigorous measurement and control standards. Their commitment to advancing state-of-the-art design ensures that they remain a preferred vendor for high-stakes bioprocessing environments where accuracy and reliability are paramount.
How much funding has Broadley-James raised?
Broadley-James has raised a total of $12.7M across 3 funding rounds:
Debt
$1M
Debt
$5.2M
Debt
$6.4M
Debt (2020): $1M with participation from PPP
Debt (2026): $5.2M, investors not publicly disclosed
Debt (2026): $6.4M supported by Harvest Commercial Capital
Key Investors in Broadley-James
Harvest Commercial Capital
A specialized financial institution providing commercial lending solutions and debt financing to support the growth and operational needs of established industrial enterprises.
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed investor participating in the most recent funding round to provide strategic capital for enterprise-level expansion.
What's next for Broadley-James?
With the recent capital deployment, Broadley-James is well-positioned to accelerate its research and development initiatives, focusing on the next generation of automation and control systems. The strategic allocation of these funds will likely prioritize the expansion of manufacturing capabilities to meet the rising global demand for bioprocess tools. As the company navigates this growth phase, the focus will remain on integrating advanced sensor technology into broader industrial ecosystems, thereby enhancing operational efficiency for its client base. This strategic trajectory suggests a move toward deeper market penetration in the life sciences and industrial manufacturing sectors, leveraging their established reputation for technical excellence to capture additional market share.
See full Broadley-James company page
